Investment Trusts

The Biotech Growth Trust PLC

BIOG:LSE

The Biotech Growth Trust PLC

Actions
  • Price (GBX)748.00
  • Today's Change6.00 / 0.81%
  • Shares traded119.20k
  • 1 Year change-21.59%
  • Beta0.4500
Data delayed at least 20 minutes, as of Jul 04 2025 16:35 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Total returns on £1000

1Y
Fund/benchmarkChange
PriceThe Biotech Growth Trust PLC (Ordinary Share)-22.06%
NAVThe Biotech Growth Trust PLC (Ordinary Share)-22.48%
Morningstar's BenchmarkNASDAQ Biotechnology TR GBP--

Key statistics

On Friday, The Biotech Growth Trust PLC (BIOG:LSE) closed at 748.00, 22.08% above the 52 week low of 612.70 set on Apr 09, 2025.
52-week range
Today
612.70Apr 09 20251,068.36Oct 07 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding25.92m
Market cap185.55m GBP
Total assets213.11m GBP
Total expense ratio1.12%
High748.00
Low736.00
Previous close742.00
Average volume133.29k
YTD Change-12.51%
Beta0.4500
Diluted NAV (est)808.25
Diluted NAV (last pub)806.85
Premium/Discount-7.45%
Net Gearing+7.19%
Data delayed at least 20 minutes, as of Jul 04 2025 16:35 BST.
More ▼

Board of Directors

1/7

Roger Yates, Chairman

2/7

Geoff Hsu

3/7

Lord Willetts

4/7

Julia Le Blan

5/7

Dr Nicola Shepherd

6/7

Hamish Baillie

7/7

Julie Tankard

Contact

The Biotech Growth Trust PLC:
25 Southampton Buildings
London
WC2A 1AL

T: 0203 008 4910
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.